Intrathecal drug delivery system complications: Difference between revisions
ClaireLewis (talk | contribs) |
ClaireLewis (talk | contribs) |
||
| Line 18: | Line 18: | ||
**[[Opioid toxicity]] | **[[Opioid toxicity]] | ||
**[[Clonidine toxicity]] | **[[Clonidine toxicity]] | ||
**[[Local anesthetic toxicity]] | **[[Local anesthetic systemic toxicity]] | ||
**[[Baclofen toxicity]] | **[[Baclofen toxicity]] | ||
**[[Respiratory failure|Respiratory depression]] is feared effect of most | **[[Respiratory failure|Respiratory depression]] is feared effect of most | ||
Revision as of 16:37, 28 October 2019
Background
- Used for delivery of short or long acting pain or anti-spasmodic medications into the thecal space
- Allows for smaller doses and fewer systemic side effects
- Most common Intrathecal medications
Clinical Features
Differential Diagnosis
Complications:
- Overdose of medication, see:
- Opioid toxicity
- Clonidine toxicity
- Local anesthetic systemic toxicity
- Baclofen toxicity
- Respiratory depression is feared effect of most
- Infection
- Local cellulitis
- Meningitis
Evaluation
Management
- The device is not removed in an overdose but should be turned off.
- Insertion of a 22-guage needle into the pump reservoir can remove all medication in case device cannot be turned off
- Consider naloxone to reverse opioid effects taking into account patients chronicity of treatment if they withdrawal
- Treat infection aggressively with antibiotics
- May be treated without device removal with combination of IV and intrathecal antibiotics[1], but consult ID and/or anesthesia/appropriate surgical specialty as device may need to be removed
Disposition
See Also
External Links
References
- ↑ Aristedis R, Dimitrios P, Nikolaos P, Alexandros B. Intrathecal baclofen pump infection treated by adjunct intrareservoir teicoplanin instillation. Surg Neurol Int. 2017;8:38.